Omschrijving
This book brings together an international group of clinicians and researchers from a broad swath of inter-related disciplines to offer the most up-to-date information about clinical and preclinical research into ketamine and second-generation “ketamine-like” fast-acting antidepressants. Currently available antidepressant medications act through monoaminergic systems, are ineffective for many individuals suffering from depression, and are associated with a delayed onset of peak efficacy of several months. The unexpected emergence of ketamine, an anesthetic N-methyl-D-aspartate (NMDA) receptor antagonist, as a rapid-acting antidepressant has reinvigorated CNS drug discovery research and catalyzed investigation in patient populations historically ignored in antidepressant drug development pr
Kenmerken
| Artikelnummer | 9200000076374607 |
|---|---|
| EAN | 9783319429250 |
| Categorie | Digital Reading |
| Productgroep | Boeken |
| Segment | Textual/Printed/Reference Materials |
| Prijs Nederland | € 87,99 |
| Prijs België | € 87,99 |
| Verzendkosten NL | Gratis |
| Verzendkosten BE | Gratis |
| Levertijd Nederland | Morgen in huis |
| Levertijd België | Morgen in huis |
| Verkoper | Partner |
Ketamine for Treatment-Resistant Depression bestellen bij snelkeus
Koop Ketamine for Treatment-Resistant Depression van Onbekend online in de categorie Digital Reading. Prijs € 87,99, levering in Nederland · Morgen in huis.